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Abstract
Objectives: The etiology of Inflammatory myofibroblastic tumor(IMT) is contentious. In this study, we used
computed tomography (CT) to examine tonsillar IMT and further analyzed the etiology of this entity.
Methodology: We presented CT features of left tonsillar IMT and reviewed the English-language literature
published between 1984 and 2011.
Results: To our knowledge, there are only six published cases of tonsillar IMT including the present case. Two
patients were asymptomatic at initial presentation. Two patients were taking immunosuppressants, and one was
pregnant and in an immunomodulated state. CT of our patient revealed a 2.6 × 1.8 cm irregular soft tissue mass
between the left tonsil and the base of the tongue. It did not invade surrounding structures and was not
enhanced on contrast-enhanced imaging.
Conclusions: Tonsillar IMT may be a benign tumor. We suggest that preoperative recognition of tonsillar IMT by
CT may be important to avoid unnecessary expanded surgery.
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Background
Inflammatory myofibroblastic tumor (IMT) is a rare
mesenchymal tumor [1]. The etiology of IMT is conten-
tious, and debate exists as to whether IMT is benign or
malignant [1-3]. Some IMTs are found to be associated
with systemic inflammatory disorders [1,4], autoimmune
diseases [5], or neoplasms [6]. Its prognosis and behavior
are controversial. Most patients with IMT have a good
prognosis and can be cured by resection. Recent evidence
shows that IMTs may have different etiologies and clinico-
pathologic features at different sites [3,7,8].
Tonsillar IMT is rare; we reviewed the English-litera-
ture regarding tonsillar IMT and only five previous
reports covered this topic [9-13]. Two of the five patients
were taking immunosuppressants, and one was pregnant
and in an immunomodulated state. We herein report the
sixth case of tonsillar IMT in the English-language litera-
ture in an immunocompetent pat i e n ta n df i r s td e s c r i b e
the computed tomography (CT) imaging features of ton-
sillar IMT.
Case presentation
A 51-year-old woman presented with a 3-year history of a
progressively enlarging mass in the left palatine tonsil. The
mass had been approximately 0.5 × 0.5 cm during a rou-
tine check-up 3 years previously. The patient denied sore
throat, fever, malaise, dysphagia, and dyspnea. The patient
had no history of generalized immune deficiency, leuke-
mia, malignant disease, diabetes mellitus, or use of immu-
nosuppressive drugs, including corticosteroids. The
patient also denied alcohol and tobacco abuse and any
previous surgery or trauma. The patient had not visited a
doctor for evaluation of the mass. Six months prior to pre-
sentation, the patient felt a dry itch in her throat and the
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any medium, provided the original work is properly cited.mass had progressively enlarged. In June 2011, the patient
presented to our department. Physical examination
showed a 2.5 × 2 cm irregular mass in the upper pole of
the left palatine tonsil. There was no adenopathy. The rest
of the physical examination results were normal. CT of
the pharynx showed a 2.6 × 1.8 cm irregular soft tissue
mass between the left tonsil and the base of the tongue
(Figure 1A) with no enhancement on contrast-enhanced
imaging, and no enlargement of the lymph nodes (Figure
1B). Laboratory examination revealed a normal complete
blood count and normal erythrocyte sedimentation rate.
Serological tests were positive for anti-Epstein-Barr virus
( E B V )I g Ga n da n t i -c y t o m e g alovirus (CMV) IgG, and
negative for anti-EBV IgM, anti-CMV IgM, and anti-
human immunodeficiency virus (HIV) antibodies. There
were no other abnormalities on systemic or dermatological
examinations. Chest X-ray and abdominal ultrasonography
(USG) results were normal.
On June 17, 2011, the mass and left tonsil were excised
completely under general anesthesia without any
complications (Figure 1C). Pathological analysis of frozen
sections showed an inflammatory pseudotumor. Routine
pathological examination demonstrated that the tumor
was composed of short spindle cells arranged in a weav-
ing pattern. The spindle cells in some areas were rich;
some cells showed atypia and mitosis and were mixed
with inflammatory cells, such as lymphocytes, and plasma
cells arranged as clusters (Figure 2A). Immunohisto-
chemical (IHC) analysis was positive for the expression
of desmin (Figure 2B), and focally positive for S-100 pro-
tein. In contrast, IHC analysis was negative for CD117,
CD34, smooth muscle actin, caldesmon, and cytokeratin.
Further molecular pathological investigation by polymer-
ase chain reaction (PCR) did not reveal CMV or EBV
infection. There was no evidence of recurrence after 8
months of follow-up.
Conclusions
IMT may occur at nearly every site of the body [8],
including the lungs [3], hypopharynx [4], central
Figure 1 CT of pharynx showed that a 2.6 cm × 1.8 cm irregular soft tissue mass between the left tonsil and the base of the tongue
(A), with no enhanced on contrast-enhanced imaging(B).C: The mass and left tonsil were excised completely. D: surgical specimen.
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[7], and oral cavity [8]. Tonsillar IMT is rare. In 1984,
Weilbaecher et al. were the first to report IMTs of the
tonsil [12]. We reviewed the English-language literature
regarding IMTs of the tonsil from 1984 to 2011, and
only six cases were reported (including the case
described herein) (Table 1) [9-13]. The patient group
consisted of two males and four females. The age of the
patients ranged from 10 to 63 years at initial presenta-
tion, with a mean age of 43 years. The symptoms
included sore throat, odynophagia, pain in the neck
region, cough with vomiting, and dyspnea (in a young
female). Two patients were asymptomatic at initial pre-
sentation, one had only an enlarged tonsil, and one had
a mass in the left tonsil. There were four cases with
IMT located in the left tonsil and two cases with IMT
in the right tonsil.
Although debate exists as to whether IMT is a pseudo-
tumor or a neoplasm, the concept of IMT as a neoplasm
was recently solidified [7] with the discovery of cytogenetic
aberrations and the subsequent recognition of ALK gene
rearrangements on the short arm of the chromosome as a
recurrent aberration [8]. However, the etiology, benign or
malignant nature, and prognosis of IMT remain unknown
and controversial. Our previous reports and other studies
revealed that IMTs originating in different organs may
lead to diverse etiologies and clinicopathologic features
[2,3,7,8]. Etiologies at the other sites may be infectious
[14], traumatic [15], or autoimmune syndromic [5].
Viruses that are suspected to be involved in the develop-
ment of IMTs include HIV [16], HHV-8 [4], and EBV
[17]. Some investigators consider it to be an immunologic
response to an infectious agent [16,17]. For tonsillar IMT,
two patients were in an immunodepressive state [11,12]
and one was a pregnant woman [10]. The patient with
IMT of the tonsil, reported by Newman and Shinn (1995),
had been on long-term prednisone for asthma and retro-
peritoneal fibrosis [12]. Gangopadhyay et al. reported that
Figure 2 Routine pathological examination demonstrated that the tumour was composed of short spindle cells arranged as weaving.
The spindle cells in some areas were rich and some cells were atypia and mitotic, mixed with inflammatory cells such as lymphocytes and
plasma cells arranged as cluster(A:HE × 40). Immunohistochemical analysis was positive for the expression of desmin(B: EliVision × 40) and AKT(3
C: EliVision × 40), focal positive for S-100 protein(D: EliVision × 40).
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immunosuppressants following cadaveric renal transplant
9 years previously [11]. Magill et al. reported a pregnant
woman with IMT in the right tonsil [10]. They suggested
that pregnancy is an immunomodulated state, even during
the earliest gestational period [10]. The present patient
was immunocompetent.
Magill et al. mentioned that CT confirmed the presence
of an enlarged right tonsil along with right-sided nodes,
but did not supply any CT imaging [10]. Here, we first
describe CT imaging of tonsillar IMT. CT revealed a 2.6 ×
1.8 cm irregular soft tissue mass between the left tonsil
and the base of the tongue that did not invade surround-
ing structures and was not enhanced on contrast-
enhanced imaging. These findings suggested that the mass
might have been a benign tumor. The results were con-
firmed by surgery and pathology. The surgical specimen
showed a smooth surface with some small nodules, which
lead to the appearance of an irregular soft tissue mass on
CT imaging. Thus, preoperative recognition of this benign
lesion on CT is important to avoid unnecessary radical
resection. Our imaging findings were not similar to those
of other IMTs in the head and neck [18]. Most IMTs on
contrast-enhanced images show early enhancement, and
sinonasal IMTs have a more aggressive appearance [18].
On CT, a moderately enhanced mass is usually seen in
orbital IMTs, accompanied by fat infiltration or edema
[18]. Our case showed no enhancement on contrast-
enhanced imaging and did not involve surrounding tissue.
IMTs arising in mesenteric, omental, peritoneal, pel-
vic, and retroperitoneal sites [19], and the maxillary
sinus [20] tend to recur, with a potential for metastatic
spread in rare instances [2,3,20]. In the six tonsillar
IMTs reported, there were no recurrences or metastases.
This suggests that tonsillar IMTs may be benign and
have a good outcome. However, the prognosis, recur-
rence, and metastatic rate have not been confirmed in a
larger series, and there is a lack of long-term follow-up.
The optimal treatment for IMTs at other sites is still
controversial, but excision of the tonsils with IMT,
either by tonsillectomy or excision with a CO2 laser,
s e e m st ob ea ne f f e c t i v et r e a t m e n tb a s e do nt h eo u t -
come of four tonsillar IMTs [10-12]. Treatment experi-
ence will continue to accumulate along with increases in
the number of tonsillar IMTs.
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Table 1 Clinical Features of IMT Cases in the tonsil
Author Age/
sex
past history Symptom Size
(cm)
Duration Treatment Follow-
up
Present 51/F no past medical history of note A progressive enlarged
mass in the left tonsil
2.6 ×
1.8
3 yrs Tonsillectomy
(left)
3m ,
NED
Grube-Pagola
et al (2011)
12
10/F no past medical history of note pain in the neck region,
cough with vomiting,
dyspnoea and dyslexia
5.2 ×
2.4 ×
1.5
11 m Bilateral
tonsillectomy
(lesion in the
left tosil)
NA
Magill
et al (2010)
13
28/F pregnant woman sore throat, fever and
malaise
NA 10-day CO2 laser
(right)
13 m,
NED
Gangopadhyay
et al (1997)
14
41/
M
chronic renal failure received a cadaveric renal
transplant, HCV+, prednisone, azathioprine, enalapril
cyclosporine since renal transplant.
lump in the throat,
odynophagia
2×2
×2
2 m Tonsillectomy
(left)
10 m,
NED
Newman et al
(1995)
15
62/F Asthma, retroperitoneal fibrosis,
Prednisone(o.d)
odynphagia 3.5 ×
2.5 ×
2
2 m Tonsillectomy
(left)
16 m,
NED
Weilbaecher
et al (1984)
16
63/
M
no past medical history of note an enlarged right tonsil 2.5 ×
1.5 ×
1
NA Tonsillectomy
(right)
NA
NA not available; NED no evidence of disease.
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